A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Insulin Icodec; Drug: Semaglutide Sponsor: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials
